Results 201 to 210 of about 2,786,170 (244)

Cadmium Toxicity in <i>Caenorhabditis elegans</i>: Mechanisms and Interventions by Vitamin C and Fruit Juices. [PDF]

Foods
Zhao Y, Wang S, Zhang H, Lu X, Sun H, Hu H, Hu L, Zhai L, Zhou W, Mo H.   +9 more
europepmc   +1 more source

<i>DPYD</i>-guided fluoropyrimidine dose adjustment in colorectal cancer <i>DPYD</i> carriers: start slower to finish stronger. [PDF]

Front Pharmacol
Rosas-Alonso R, Salas NR, Wert PP, Hoyo A, Martin-López S, Martínez-Pérez D, Ruiz-Gutiérrez I, Jiménez-Bou D, Peña J, Arias P, Custodio A, Losantos-García I, Borobia AM, Feliu J, Ghanem I.   +14 more
europepmc   +1 more source

Bilateral methanol-induced optic neuropathy following hand sanitizer ingestion. [PDF]

Am J Ophthalmol Case Rep
Sherman CS, Oatts JT, Sarlo D.
europepmc   +1 more source

Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer. [PDF]

Immunotargets Ther
Huang S, Huang L, Zhang D, Jiang Q, Wang F, Guo G.   +5 more
europepmc   +1 more source

State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer. [PDF]

Korean J Radiol
Eid S, Al-Yousef AS, Kim KW, Yoon S, Nawfal R, Bellmunt J, Choueiri TK, Krajewski KM.   +7 more
europepmc   +1 more source

Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review. [PDF]

Cancers (Basel)
Grujić M, Volchenkov S, Akhmetali A, Živković Radojević M, Milosavljević N, Janković K, Krasić K, Mihajlović M, Shelan M, Nicosia L, Marinković M.   +10 more
europepmc   +1 more source

Metal nanoparticles in cancer theranostics: from synthesis to tumor microenvironment-responsive applications. [PDF]

Drug Deliv
Jiang L, Fu Z, Ye B, Feng X, Chen Z, Chen Q, Long Y, Wang S, Deng G.   +8 more
europepmc   +1 more source

Toxicity of interferon.

BMJ, 1981
openaire   +6 more sources

Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047. [PDF]

J Immunother Cancer
Regan MM, Ascierto PA, Lipson EJ, Palaia J, Moshyk A, Selvan A, Lao CD, Atkins MB, McDermott DF, Potluri R, Ranjan S, Bilthare S, Long GV, Stephen Hodi F, Tawbi H, Schadendorf D.   +15 more
europepmc   +1 more source

Longitudinal Ellipsoid Zone Dynamics During Hydroxychloroquine Use. [PDF]

J Pers Med
Matar K, Talcott KE, Ugwuegbu O, Hu M, Srivastava SK, Reese JL, Ehlers JP.   +6 more
europepmc   +1 more source